Effect of Pycnogenol® on attention-deficit hyperactivity disorder (ADHD): study protocol for a randomised controlled trial

BACKGROUND: Methylphenidate (MPH), the first choice medication for attention-deficit hyperactivity disorder (ADHD), is associated with serious adverse effects like arrhythmia. Evidence on the association of ADHD with immune and oxidant-antioxidant imbalances offers potential for antioxidant and/or i...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Trials
Main Authors: Verlaet, Annelies A. J., Ceulemans, Berten, Verhelst, Helene, Van West, Dirk, De Bruyne, Tess, Pieters, Luc, Savelkoul, Huub F. J., Hermans, Nina
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2017
Teme:
Study Protocol
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5370458/
https://ncbi.nlm.nih.gov/pubmed/28351412
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-017-1879-6
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki